ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO040

Epidemiologic Investigation of Contrast-Induced AKI Based on an In-Hospital Electronic Monitoring System

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Zheng, Xingyue, Ningbo No 2 Hospital, Ningbo, Zhejiang, China
  • Xu, Youjun, Ningbo No 2 Hospital, Ningbo, Zhejiang, China
  • Zhou, Fangfang, Ningbo No 2 Hospital, Ningbo, Zhejiang, China
  • Luo, Qun, Ningbo No 2 Hospital, Ningbo, Zhejiang, China
Background

With the gradual promotion of cardiovascular disease interventions , contrast-induced acute kidney injury (CI-AKI) has become the third most common cause of medically induced kidney injury. Patients with CI-AKI have a poor prognosis, which increases the incidence of end-stage renal disease and the risk of death, and the 2-year survival rate for patients with CI-AKI requiring dialysis is only 18.8%.AKI alerts and corresponding interventions based on electronic surveillance system data have been shown in selected studies to improve AKI patient regression, reduce AKI-related mortality, and decrease hospital length of stay.

Methods

11,874 adult inpatients who underwent angiography with contrast agents at Ningbo No. 2 Hospital from June 1, 2019 to April 30, 2024 were included, and patients with CI-AKI were screened by an in-hospital electronic monitoring system according to the Kidney Disease Improvement Global Prognosis Organization (KDIGO) criteria.

Results

Of the 11,874 hospitalized patients, 63.36% were male, with an age distribution of 2.08% between 18 and 40 years old, 39.49% between 41 and 65 years old, and 58.43% 66 years old and over.The electronic monitoring system detection rate was 10.49% (1245/11874), of which only 7.47% (93/1245) patients with CI-AKI were invited to nephrologists for consultation, and only 5.30% (66/1245) patients with CI-AKI were discharged with a diagnosis that included an AKI-related diagnosis (acute renal insufficiency/acute renal failure/acute renal damage/acute kidney injury). Of the CI-AKI patients, 46.67% (581/1245) were medical patients, 22.41% (279/1245) were surgical patients, and 30.12% (375/1245) were in intensive care medicine.

Conclusion

The majority of physicians have insufficient knowledge of CI-AKI, serious underdiagnosis, and low consultation rate in nephrology. The establishment of an in-hospital electronic monitoring system is extremely important for improving the prevention and diagnosis of AKI and improving the prognosis of patients.

Funding

  • Government Support – Non-U.S.